Health Care & Life Sciences » Pharmaceuticals | Chugai Pharmaceutical Co. Ltd.

Chugai Pharmaceutical Co. Ltd. | Cash Flow

Fiscal year is January-December. All values JPY Millions.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
51,886
52,077
62,353
54,372
73,540
93,079
Depreciation, Depletion & Amortization
14,490
14,880
15,567
16,369
16,334
16,578
Other Funds
1,092
1,069
1,491
2,229
406
5,128
Funds from Operations
53,929
37,518
63,266
75,239
93,424
114,783
Changes in Working Capital
-
-
-
36,159
14,465
4,486
Net Operating Cash Flow
53,929
37,518
63,266
39,080
107,889
119,269
Capital Expenditures
14,964
19,167
24,839
36,422
44,526
Sale of Fixed Assets & Businesses
-
794
-
-
64
Purchase/Sale of Investments
1,338
3,581
19,753
26,011
7,030
Net Investing Cash Flow
13,632
14,841
45,624
10,408
36,989
Cash Dividends Paid - Total
22,874
24,520
28,375
31,677
30,054
Net Financing Cash Flow
23,158
24,382
28,460
33,407
29,558
Net Change in Cash
19,625
1,032
12,331
6,339
43,705
Free Cash Flow
42,342
21,286
44,899
8,905
75,008
Other Sources
-
-
-
4
452
Change in Capital Stock
808
1,207
1,406
499
902
Exchange Rate Effect
2,486
673
1,513
1,604
2,363
Other Uses
6
49
1,032
-
8

About Chugai Pharmaceutical Co.

View Profile
Address
Nihonbashi Mitsui Tower, 15/F
Tokyo Tokyo 103
Japan
Employees -
Website http://www.chugai-pharm.co.jp
Updated 07/08/2019
Chugai Pharmaceutical Co., Ltd. engages in the research, development, manufacturing, sale, importation, and exportation of the pharmaceuticals. Its operations are carried out through the following business divisions: Research, Development, Production, Marketing, Medical Affairs and Drug Safety. The Research division focuses its efforts on creating innovative drugs by using its competitive strengths that include proprietary antibody technologies and cutting-edge research resources.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.